NEW YORK/LONDON (Reuters) - Pfizer Inc, the world’s largest drugmaker by revenue, is in talks to acquire rival Wyeth (NYSE:WYE - News) in a deal that could be valued at more than $60 billion, according to the Wall Street Journal.
NEW YORK/LONDON (Reuters) - Pfizer Inc, the world’s largest drugmaker by revenue, is in talks to acquire rival Wyeth (NYSE:WYE - News) in a deal that could be valued at more than $60 billion, according to the Wall Street Journal.
